Alcohol-branded merchandise includes T-shirts, hats or other items that have a particular brand of beverage, according to background information in the article. Increasing evidence that this special type of marketing effectively reaches teenagers and is associated with alcohol consumption. rx pills

Editorial: Measures required to alcohol-branded merchandise Regulate The evidence is strong, risk of alcohol exposure to alcohol marketing the chance early initiation, which in turn increases the young people a higher risk of alcohol – related harm, wrote David H. Jernigan, of the Johns Hopkins Bloomberg School of Public Health in Baltimore, in an accompanying editorial. – Voluntary approaches have been ineffective in reducing the risk of both political will is required to improve the data collection and reporting and to restrictions that young people move to a chance to grow alcohol – free McClure et al provide important new. Evidence. An urgent need for action .

Cardium Therapeutics and its subsidiary Tissue Repair Company announced the completion of recruiting to the groundbreaking Phase 2b the MATRIX study to safeguard the security and efficiency Excellarate the evaluate product candidate for potential treatment of from non-healing ulcers in patients with type I or type II to diabetes. Excellarate is to only one or two requires medical administered treatments contrast to most of diabetics wound healer or components into use requiring repeated administrations for long period of time .

Actual results may vary well differ materially from those as described and consideration this news release taken due to risks and uncertainties at our facilities and business environment, exist including, without limitation, risk and uncertainty, the complexities arising from the developing of biologic and are therapeutic hypothermia units and accelerate the implementing of clinical studies in humans, including the date, expense and outcome of such trials, our ability, financing necessary, regulatory approvals and the expected qualifications, our capacity successfully commercialize our therapeutic hypothermia equipment and introduction of new equipment obtain within the periods provided proprietary technology, our history of operating losses and accumulated deficits, our confidence in cooperative relationship and critical HR and current and future competition and other risks referenced described from time to to in the submissions we are making with the Securities and Exchange Commission. We will assume no liability to publicly release the results of any revisions to these forward – looking statements to reflect event or circumstances that. Accordance with the date of this release.